Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Iroson-F Syrup is an oral hematinic combination product developed and marketed by Obsons Pharmaceuticals. It contains elemental iron and folic acid, which are essential nutrients for the production and maturation of red blood cells. Elemental iron is a critical component of hemoglobin, the protein responsible for oxygen transport in the blood, while folic acid (Vitamin B9) is necessary for DNA synthesis and the proper maturation of erythrocytes. This formulation is primarily indicated for the prevention and treatment of iron-deficiency anemia and folic acid deficiency, particularly during periods of increased demand such as pregnancy and lactation.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on elemental iron + folic acid.